1,2-DITHIOL-3-THIONE AND DITHIOESTER ANALOGS - POTENTIAL RADIOPROTECTORS

被引:12
作者
TEICHER, BA
STEMWEDEL, J
HERMAN, TS
GHOSHAL, PK
ROSOWSKY, A
机构
[1] JOINT CTR RADIAT THERAPY,BOSTON,MA 02115
[2] MACROCHEM CORP,BILLERICA,MA 01821
关键词
D O I
10.1038/bjc.1990.221
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Several l, 2-dithiol-3-thione and dithioester compounds were assayed for radioprotective capabilities in EMT6 cells in vitro. The l, 2-dithiol-3-thiones were generally more cytotoxic than the dithioesters and in some instances were more cytotoxic toward hypoxic cells than toward normally oxygenated cells. When the drugs were present at a concentration of 500 μM for 1 h prior to and during radiation delivery, the 5-(2-thienyl)-l, 2-dithiol-3-thione produced a radiation protection factor (RPF) of 2. 7 at 1 log of cell kill. The 4-methyl analogue of this same compound was, however, much less effective, producing a RPF of only 1. 2. The 4-ethoxycarbonyl analogue was moderately active, producing a RPF of 1. 7. The 4-methyl-5-(2-pyrazinyl)-dithiol-3-thione (Oltipraz) was least effective, yielding a RPF of only 1. 1. Of the dithioesters tested, methyl 3-pyrrolidino-2-phenylpropene dithiocarboxylate produced a RPF of 2. 6, methyl 3-piperidino-2- phenylpropenedithiocarboxylate a RPF of 2. 7, and the corresponding 3-morpholino and 3-thiomorpholino derivatives RPF values of 2. 7 and 2. 9, respectively. The iodide salt of 4-ethoxycarbonyl-5-(2-thienyl)-l, 2- dithiol-3-thione produced a RPF of 2. 6 Methyl 3-cyclohexylamino-2-phenylpropenedithiocarboxylate was equally effective (RPF = 2. 6). Finally, methyl 3-morpholino-3-thienyl-2-methylpropenedithiocarboxylate and methyl 3-morpholino-3-(2-pyrazinyl)-2-methylpropenedithiocarboxylate were less effective, producing RPF values of 2. 0 and 1. 6, respectively. These results demonstrate that several of these compounds are highly effective radioprotectors. In vitro and in vivo studies testing their efficacy are underway. © The MacMillan Press Ltd., 1990.
引用
收藏
页码:17 / 22
页数:6
相关论文
共 23 条
[1]   BIOCHEMICAL EFFECTS OF DITHIOLTHIONES [J].
ANSHER, SS ;
DOLAN, P ;
BUEDING, E .
FOOD AND CHEMICAL TOXICOLOGY, 1986, 24 (05) :405-415
[2]   THE CHEMOTHERAPY OF SCHISTOSOMIASIS [J].
ARCHER, S .
ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY, 1985, 25 :485-508
[3]  
BUEDING E, 1982, RES COMMUN CHEM PATH, V37, P293
[4]   PROTECTION BY WR-2721 OF HUMAN-BONE MARROW FUNCTION FOLLOWING IRRADIATION [J].
CONSTINE, LS ;
ZAGARS, G ;
RUBIN, P ;
KLIGERMAN, M .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1986, 12 (08) :1505-1508
[5]   DITHIOLTHIONE-INDUCED ALTERATIONS IN HEPATIC GLUTATHIONE AND RELATED ENZYMES IN MALE-MICE [J].
DAVIES, MH ;
BLACKER, AM ;
SCHNELL, RC .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (04) :568-570
[6]  
DELONG MJ, 1986, CARCINOGENESIS, V7, P977
[7]   ANTIRADIATION COMPOUNDS .22. METHYL 3-AMINO-2-PHENYLDITHIOPROPENOATES AND 1,1-BIS(METHYLTHIO)-3-AMINO-2-PHENYL-1-PROPENES [J].
FOYE, WO ;
JONES, RW ;
GHOSHAL, PK .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1987, 76 (10) :809-812
[8]   CLINICAL-TRIALS OF WR-2721 AND CIS-PLATINUM [J].
GLOVER, D ;
GRABELSKY, S ;
FOX, K ;
WEILER, C ;
CANNON, L ;
GLICK, J .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 16 (05) :1201-1204
[9]  
HAUSLER R, 1979, REV SUISSE PRAXIS ME, V68, P1063
[10]  
HELMES C T, 1989, Proceedings of the American Association for Cancer Research Annual Meeting, V30, P177